In this episode of SurgOnc Today, we will discuss a few of the practice changing trials presented at the American Society of Clinical Oncology annual meeting this past June. The episode is moderated by Dr. Kelly Hewitt and offers insightful discussion by leaders in medical oncology, including Dr. Jo Chien, Dr. Laura Kennedy and Dr. William Gradishar. Highlights include discussion of results from COMPASS Her2, SERENA-6 and the current state and utility of circulating tumor DNA in patients with early-stage breast cancer.

In this series "Evidence Today and Tomorrow", the HPB disease site working group of the SSO explored current gaps in HPB surgical oncology, highlighting existing evidence and ongoing work aimed at filling those gaps. In this episode, Dr. Julie Hallet, chair of the HPB disease site working group, and Dr. Noah Cohen, member of the HPB disease site working group, are joined by Drs. Michael Lidksy and Bas Groot Koerkamp to review evidence in hepatic artery infusion pump therapy.

In this episode of SurgOnc Today, Drs. Abhineet Uppal and Shirin Sabbaghian Hebert will discuss management considerations for the treatment of lateral pelvic nodes in patients with rectal cancer. We have the great opportunity to speak with Dr. Tsuyoshi Konishi (MD-PhD), who has maintained an essential role within the Lateral Node Study Consortium. He is a great resource of knowledge in this field as he trained at the University of Tokyo in Japan, where lateral node dissection is performed more routinely for patients with rectal cancer. Following his training, he worked at the Cancer Institute Hospital of the JFCR in Tokyo as faculty for a decade. . We are fortunate to have him working with us here in the United States as Associate Professor of Surgery at MD Anderson.

In the premiere episode of Outside the OR, host Dr. Russell Berman sits down with surgical oncologists Dr. Bridget Fahy and Dr. EeeLN Buckarma for an insightful conversation on the critical role of palliative care in surgical oncology. Whether you're a surgical oncologist, trainee, or healthcare professional, you'll gain valuable perspectives on why good palliative care is truly good surgical care.

In this episode of SurgOnc Today, Dr, Zahraa AlHilli is joined by Dr. Christine Klassen, Dr. Wendie Berg, and Dr. Jennifer Harvey discuss what it means when patients receive a mammogram result of "dense breasts", including the risk of cancer being missed on a mammogram and also the risk of developing breast cancer in the context of family history and other factors. The group will further detail options for supplemental screening with MRI, ultrasound, or, in the future, contrast-enhanced mammography and uses of AI in breast imaging.

In this new episode of Speaking of SurgOnc, Dr. Rick Greene discusses with Dr. David Seo recent and ongoing high-impact clinical trials that analyze the multidisciplinary treatment of pancreatic ductal adenocarcinoma, as reported in the article, "The Landmark Series: The Future of Pancreatic Cancer Clinical Trials."

In this episode of SurgOnc Today, Drs. Oluwadamilola "Lola" Fayanju and Jose Trevino moderate a conversation with Drs. Ugwuji Maduekwe and Rebecca Snyder on the importance of patient diversity in clinical trials as they also provide systemic, investigator-led, and patient-level strategies to facilitate enrollment of diverse trial participants.

Dr. Daniel Shapiro, Section Editor of the Urologic Oncology Editorial Board section of Surgical Oncology Insight, discusses with Dr. Marcelo Bigarella a review of the treatment options for patients with locally advanced prostate cancer. Dr. Bigarella is the author of "Multidisciplinary management of nonmetastatic locally advanced prostate cancer (T3-4N0M0)," published in the June 2025 issue of the journal.

In this episode of SurgOnc Today, Dr. Yinin Hu from the University of Maryland and Dr. Jennifer Kuo from the Columbia University Medical Center discuss current evidence, best practices, and future directions for percutaneous ablative therapy for thyroid cancer.

In this series "evidence today and tomorrow", the HPB disease site working group of the SSO explored current gaps in HPB surgical oncology, highlighting existing evidence and ongoing work aimed at filling those gaps. In this episode of SurgOnc Today, Dr. Julie Hallet from the Unviersity of Toronto and chair of the SSO HPB Disease Site Working Group, and Dr. Winnie Lo from Eastern Virginia Medical School are joined by Dr. Adam Yopp and Dr. Amit Singal from UT Southwestern, and Dr. Katie Kelley from University of California San Francisco. They will be discussing the state-of-the-art evidence and upcoming trials on treating hepatocellular carcinoma.